Halozyme To Present At Canaccord Genuity 40th Annual Growth Conference
Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced that Dr. Helen Torley, president and chief executive officer, will participate in the upcoming Canaccord Genuity 40th Annual Growth Conference. Dr. Torley will take part in a fireside chat at 8:30 a.m.
PR Newswire · 2天前
Subcutaneous version of J&J's Darzalex OK'd in Canada
Health Canada has approved a subcutaneous formulation of Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical Companies' multiple myeloma med Darzalex
seekingalpha · 2天前
Halozyme Therapeutics (HALO) Reports Next Week: Wall Street Expects Earnings Growth
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 3天前
Halozyme To Host Second Quarter 2020 Financial Results Webcast And Conference Call
Halozyme Therapeutics, Inc. (NASDAQ: HALO) will webcast its Quarterly Update Conference Call for the second quarter 2020 on Monday, August 10 at 4:30 p.m. ET / 1:30 p.m. PT. Dr. Helen Torley, president and chief executive officer, will lead the call. On the sa
PR Newswire · 07/29 20:05
Halozyme Therapeutics (HALO) Earnings Expected to Grow: Should You Buy?
Halozyme Therapeutics (HALO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 07/28 16:32
Biotech Bonanza - Second Half Outlook
Seeking Alpha · 07/28 12:24
Did Hedge Funds Make The Right Call On Halozyme Therapeutics, Inc. (HALO) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are